Immediate endoscopic injection therapy of bleeding oesophageal varices: a prospective comparative evaluation of injecting materials in Egyptian patients with portal hypertension
- PMID: 9617052
Immediate endoscopic injection therapy of bleeding oesophageal varices: a prospective comparative evaluation of injecting materials in Egyptian patients with portal hypertension
Abstract
The present study was conducted to compare usual sclerosants: polidocanol 1%, ethanolamine oleate 5% and the tissue adhesive: cyanoacrylate in the control of oesophageal variceal bleeding in Egyptian patients with portal hypertension in a prospective comparative trial. Sixty patients with portal hypertension due to schistosomal hepatic fibrosis and/or posthepatitic liver cirrhosis who had presented with acute oesophageal variceal bleeding were enrolled. Patients received balloon tamponade prior to injection were excluded. Resuscitation had been done before or during emergency endoscopy. Emergency endoscopy was conducted within 2 hours from the onset of hematemesis. Patients were immediately randomized during emergency endoscopy to receive polidocanol 1%, ethanolamine oleate 5% or tissue adhesive. Variceal rebleeding was managed by reinjection. The three groups were comparable for age, sex, etiology of portal hypertension, Child-Pugh class and findings at emergency endoscopy. No active bleeding was observed at the end of all injection sessions. Rebleeding had been occurred within the first 24 hours in 2 (10%) patients in polidocanol group and 3 (15%) patients in ethanolamine group (P > 0.05). Reinjection did control rebleeding in 2 (10%) patients in ethanolamine group with a total success rate of 95%. Exsanguinating rebleeding occurred in 2 (10%) patients in polidocanol group and one (5%) patient in ethanolamine group (P > 0.05). Postinjection large ulcers were diagnosed either in polidocanol (15%) or ethanolamine (10%) groups (P > 0.05). Other complications were minor and showed no significant differences between the three groups. In coclusion, polidocanol, ethanolamine and cyanoacrylate are equally safe and effective. For immediate endoscopic injection therapy an experienced team must be available.
Similar articles
-
Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver.Endoscopy. 1997 May;29(4):241-6. doi: 10.1055/s-2007-1004183. Endoscopy. 1997. PMID: 9255525 Clinical Trial.
-
Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.Hepatogastroenterology. 1992 Dec;39(6):546-8. Hepatogastroenterology. 1992. PMID: 1483669 Clinical Trial.
-
The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices.Endoscopy. 1995 Jun;27(5):358-64. doi: 10.1055/s-2007-1005714. Endoscopy. 1995. PMID: 7588349 Clinical Trial.
-
[Diagnosis and treatment of bleeding esophago-gastric varices].Nihon Rinsho. 1998 Sep;56(9):2325-30. Nihon Rinsho. 1998. PMID: 9780714 Review. Japanese.
-
Management of the patient with hemorrhaging esophageal varices.JAMA. 1986 Sep 19;256(11):1480-4. JAMA. 1986. PMID: 3528543 Review.
Cited by
-
Risk of rebleeding from gastroesophageal varices after initial treatment with cyanoacrylate; a systematic review and pooled analysis.BMC Gastroenterol. 2020 Jun 9;20(1):181. doi: 10.1186/s12876-020-01333-9. BMC Gastroenterol. 2020. PMID: 32517718 Free PMC article.
-
Management of acute variceal bleeding using hemostatic powder.United European Gastroenterol J. 2015 Jun;3(3):277-83. doi: 10.1177/2050640615570148. United European Gastroenterol J. 2015. PMID: 26137303 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical